Author

L. Graziosi

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Assay:bulk RNA-seq· 2 Research Focus:differential expression· 2 Approach:statistical model· 2 Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Assay:organoid / primary culture· 1 Research Focus:protein structure prediction· 1

Frequent Co-Authors

A. Donini· 3 shared A. Zampella· 3 shared E. Distrutti· 3 shared M. Biagioli· 3 shared S. Fiorucci· 3 shared S. Marchiano· 3 shared C. Di Giorgio· 2 shared E. Marino· 2 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersCancer Biology

A. Donini

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Bile Acids Serve As Endogenous Antagonists Of The Leukemia Inhibitory Factor (LIF) Receptor in Oncogenesis

C. Di Giorgio, E. Morretta, A. Lupia, R. Bellini, C. Massa, G. Urbani, M. Bordoni, S. Marchiano, P. Rapacciuolo, C. Finamore, V. Sepe, M. C. Monti, F. Monarca, N. Natalizi, L. Graziosi, , S. Fiorucci

The paper shows bile acids, specifically GDCA, inhibit LIFR in gastric cancer, suggesting potential for bile acid-based therapies in LIF-driven oncogenesis.

bioRxiv · Sep 30, 2023Cancer Biology

Next generation sequencing analysis of gastric cancer identifies the leukemia inhibitory factor receptor (LIFR) as a driving factor in gastric cancer progression and as a predictor of poor prognosis

C. Di Giorgio, S. Marchiano, E. Marino, M. Biagioli, R. Roselli, M. Bordoni, R. Bellini, G. Urbani, A. Zampella, E. Distrutti, A. Donini, L. Graziosi, S. Fiorucci

This study identifies LIFR as a key driver in gastric cancer progression and a predictor of poor prognosis through RNA-seq analysis of patient samples.

bioRxiv · May 5, 2022 · PreprintCancer Biology

Analysis of gastric cancer transcriptome allows the identification of histotype specific molecular signatures with prognostic potential

A. Carino, L. Graziosi, S. Marchiano, M. Biagioli, E. Marino, V. Sepe, A. Zampella, E. Distrutti, A. Donini, S. Fiorucci

This study identifies histotype-specific molecular signatures in gastric cancer using transcriptomic analysis, finding AQP9, CARD14, and CXCR2 as prognostic markers.

bioRxiv · Feb 2, 2021Cancer Biology